Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
25.58
+0.58 (2.32%)
At close: Apr 28, 2026, 4:00 PM EDT
25.82
+0.24 (0.93%)
After-hours: Apr 28, 2026, 4:35 PM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $921.35 million as of April 28, 2026.
Market Cap
921.35M
Enterprise Value
761.96M
1-Year Change
n/a
Ranking
Category
Stock Price
$25.58
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $921.35M, an increase of 91.45%. That is a compound annual growth rate of 296.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 900.46M | 66.85% |
| Dec 31, 2025 | 539.69M | 12.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 957.85M |
| Annexon | 955.54M |
| Xencor | 951.94M |
| Phathom Pharmaceuticals | 929.33M |
| Fortrea Holdings | 916.30M |
| Janux Therapeutics | 913.08M |
| Maravai LifeSciences Holdings | 912.59M |
| Compass Therapeutics | 905.84M |